ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02625623
Brief Title: Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

First Submitted : December 4, 2015
First Submitted that Met QC Criteria : December 4, 2015
First Posted : December 9, 2015 (Estimate)

Results First Submitted : September 10, 2018
Results First Submitted that Met QC Criteria : September 10, 2018
Results First Posted : October 15, 2018

Last Update Submitted that Met QC Criteria : January 3, 2019
Last Update Posted : January 15, 2019